TR200001293T2 - Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı - Google Patents

Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı

Info

Publication number
TR200001293T2
TR200001293T2 TR2000/01293T TR200001293T TR200001293T2 TR 200001293 T2 TR200001293 T2 TR 200001293T2 TR 2000/01293 T TR2000/01293 T TR 2000/01293T TR 200001293 T TR200001293 T TR 200001293T TR 200001293 T2 TR200001293 T2 TR 200001293T2
Authority
TR
Turkey
Prior art keywords
mirtazapine
during sleep
respiratory arrest
treat respiratory
arrest during
Prior art date
Application number
TR2000/01293T
Other languages
English (en)
Inventor
Stuart Andrews John
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of TR200001293T2 publication Critical patent/TR200001293T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Mirtazapin terkibinin uykuda solunum durmasi hastaligini tedavide etkin oldugu bulunmustur. Mirtazapin, ihtiyari olarak, fluoksetin gibi bir SSRI ile birlikte kullanilir
TR2000/01293T 1997-11-14 1998-11-13 Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı TR200001293T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14

Publications (1)

Publication Number Publication Date
TR200001293T2 true TR200001293T2 (tr) 2002-09-23

Family

ID=8228923

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01293T TR200001293T2 (tr) 1997-11-14 1998-11-13 Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı

Country Status (21)

Country Link
US (1) US6303595B1 (tr)
EP (1) EP1030667B1 (tr)
JP (1) JP2001522891A (tr)
KR (1) KR20010032009A (tr)
CN (1) CN1154495C (tr)
AT (1) ATE289816T1 (tr)
AU (1) AU737590B2 (tr)
BR (1) BR9815098A (tr)
CA (1) CA2309744A1 (tr)
CZ (1) CZ296282B6 (tr)
DE (1) DE69829202T2 (tr)
DK (1) DK1030667T3 (tr)
ES (1) ES2238781T3 (tr)
HK (1) HK1029932A1 (tr)
HU (1) HUP0100080A3 (tr)
IL (2) IL135825A0 (tr)
NO (1) NO20002218L (tr)
PL (1) PL192272B1 (tr)
PT (1) PT1030667E (tr)
TR (1) TR200001293T2 (tr)
WO (1) WO1999025356A1 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331536B1 (en) 1998-02-27 2001-12-18 The Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
PL206073B1 (pl) * 2000-02-11 2010-06-30 Organon Nv Zastosowanie mirtazapiny do wytwarzania leku
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
EP1667972B1 (en) 2003-09-10 2013-06-19 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines
WO2006023703A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
KR20070087678A (ko) * 2004-12-20 2007-08-28 컬리지움 파마슈티칼, 인코포레이티드 수면 장애용 약제 조성물
MX2009010967A (es) 2007-04-11 2009-12-15 Organon Nv Un metodo para la preparacion de mirtazapina.
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
WO2013188806A1 (en) * 2012-06-14 2013-12-19 The Regents Of The University Of Michigan Sleep apnea treatment
DK3261645T3 (da) 2015-02-27 2021-06-07 Dechra Ltd Stimulering af appetit, håndtering af vægttab og behandling af anoreksi hos hunde og katte

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (en) 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Derivatives of amide analogs of certain methano bridged quinolizines
DE69636393T2 (de) * 1995-10-24 2006-12-07 Grünenthal GmbH Montirelin zur verhinderung der schlafapnoe
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
PT1030667E (pt) 2005-06-30
BR9815098A (pt) 2000-10-10
ES2238781T3 (es) 2005-09-01
JP2001522891A (ja) 2001-11-20
EP1030667A1 (en) 2000-08-30
HUP0100080A3 (en) 2002-05-28
CZ20001751A3 (cs) 2000-10-11
PL340467A1 (en) 2001-02-12
DE69829202T2 (de) 2005-07-21
HK1029932A1 (en) 2001-04-20
CN1278731A (zh) 2001-01-03
DE69829202D1 (de) 2005-04-07
EP1030667B1 (en) 2005-03-02
HUP0100080A2 (hu) 2001-08-28
CZ296282B6 (cs) 2006-02-15
US6303595B1 (en) 2001-10-16
WO1999025356A1 (en) 1999-05-27
CA2309744A1 (en) 1999-05-27
NO20002218L (no) 2000-05-12
PL192272B1 (pl) 2006-09-29
KR20010032009A (ko) 2001-04-16
AU737590B2 (en) 2001-08-23
AU1754899A (en) 1999-06-07
CN1154495C (zh) 2004-06-23
DK1030667T3 (da) 2005-06-20
IL135825A0 (en) 2001-05-20
ATE289816T1 (de) 2005-03-15
IL135825A (en) 2006-12-31
NO20002218D0 (no) 2000-04-28

Similar Documents

Publication Publication Date Title
TR200001293T2 (tr) Uykuda solunum durmasını tedavi etmek için mirtazapin kullanımı
TR200102308T2 (tr) Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı
NZ515392A (en) Respiratory syncytial virus replication inhibitors
DE69830660D1 (de) Behandlung von atemstillstand im schlaf
ES2123064T3 (es) Uso de melatonina en pequeñas dosis orales como somnifero.
ATE207351T1 (de) Verwendung vonmodafinil zur behandlung von atemstillstand im schlaf und zentral erregten atembeschwerden
ATE497809T1 (de) Myricitrin verbindungen zur behandlung von schlafstörungen
DE60008143D1 (de) Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
TR199901772T2 (tr)
SE9701161D0 (sv) New use I
EE04661B1 (et) Viirus-indutseeritud ssteemse šoki ja hingamispuudulikkuse reverseerimine lmfotoksiin-beeta raja blokeerimise abil
EE200200337A (et) Uued ühendid ning nende kasutamine
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
DE69840637D1 (de) Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
ZA9711468B (en) New use of comt inhibitors
IL148336A0 (en) Medicaments that contain xenogenic oligo-or/and polyribonucleotides
NO970607D0 (no) Anordning av selegilin i behandling av epileptiske tilstander
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
PT910398E (pt) Metodo de estimulacao de cilios
DE60203895D1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines arzneimittels zur unterdrückung der nebenwirkungen von strahlentherapie und chemotherapie
BR0015424A (pt) Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
DE1608575U (de) Hocker.